74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Thermo Fisher Scientific Inc
Closed
SectorHealthcare
571.84 0.63
Overview
Share price change
24h
Min
561.7
Max
576.27
Income | 100M 1.6B |
|---|---|
Sales | 491M 11B |
P/E Sector Avg | 31.148 37.461 |
Dividend yield | 0.3 |
Profit margin | 14.878 |
Employees | 125,000 |
EBITDA | 1.1B 2.8B |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +4.77% upside |
Dividend yield Sector Avg | 0.30% 2.33% |
|---|---|
Next Ex Dividend date | 12 Dec 2025 |
Market Cap | 52B 205B |
|---|---|
Previous open | 571.21 |
Previous close | 571.84 |
News Sentiment
By Acuity
28%
72%
77 / 371 Healthcare
Technical Score
By Trading Central
Confidence
Bearish Evidence
Thermo Fisher Scientific Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Thermo Fisher Scientific Inc Forecast
Price Target
By TipRanks
4.77% upside
12 Months Forecast
Average 599.18 USD 4.77%
High 654 USD
Low 553 USD
Based on 19 Wall Street analysts offering 12 month price targets forThermo Fisher Scientific Inc - Dist in the last 3 months.
Sentiment
By Acuity
77 / 371 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
Live chat